Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Don't Ask Rambi -- Ignore unavailable to you. Want to Upgrade?

To: Gauguin who wrote (15600)	12/18/1998 12:40:00 AM
From: Ilaine	Read Replies (1) \| Respond to of 71178

The big case I worked on during 1996, 1997 and 1998 involved a young guy, a cop, who developed Hodgkin's stage IIA, and was treated with combination radiation and chemotherapy. Unfortunately, his physician misread the protocol, and gave him chemo and radiation concurrently. Unfortunately, one of the chemo agents, bleomycin, is potentiated by radiation. Radiation causes tissue damage, but concurrent bleomycin enhances it. The combination caused him to experience radiation damage to his lungs and heart comparable to that which is the result fo treatment for refractory lung cancer. I know a lot about Hodgkin's. My expert witness was Saul Rosenberg, one of the world's experts on the treatment of Hodgkin's disease.